19th Jun 2018 11:36
LONDON (Alliance News) - AorTech International PLC on Tuesday said it has signed a development deal with Vascular Flow Technologies for its synthetic heart valve project.
The biomaterials company said the project involves detailed computational modelling and analysis of AorTech's artificial heart valve. The company expects to further improve the design, manufacture and testing of the technology.
Depending on the results of the project, AorTech will consider the first "in man" testing of its heart valve.
"In partnering with the team at VFT, AorTech now has access to Europe's leading experts in the combined field of medical imaging," said AorTech Chairman Bill Brown.
"We are very excited to be a key partner in the development of the next generation of prosthetic heart valves which should represent not only a step change in performance, but dramatically reduce the cost to manufacture these life enhancing devices," added VFT General Manager Craig Dunlop.
Shares in AorTech were trading 5.6% higher at 43.50 pence per share on Tuesday.
Related Shares:
AOR.L